BETA-2-MICROGLOBULIN (SERUM)

The BETA-2-MICROGLOBULIN (SERUM) test measures the concentration of beta-2-microglobulin (B2M) in a patient’s blood serum. B2M is a low-molecular-weight protein shed by most nucleated cells and is commonly measured by immunoassay; elevated serum levels can reflect increased tumour burden in hematologic malignancies or reduced renal clearance. The test is performed on a venous blood sample collected at home by a trained phlebotomist and processed in an accredited Dubai laboratory to ensure reliable results and timely reporting.

This assay is primarily used for cancer monitoring and prognostic assessment—most notably in multiple myeloma, lymphomas, and certain chronic leukemias—where trends in B2M help clinicians evaluate disease activity and response to therapy. Results must be interpreted alongside clinical findings and renal function, since impaired kidney clearance or active inflammation can raise B2M independently of malignancy. Your Dubai-based lab report will include lab-specific reference intervals and a prompt delivery of results to support informed clinical decisions and follow-up care.

• Beta-2-Microglobulin (Serum)
• Result unit (mg/L)
• Sample type: Serum (venous blood)

• Baseline and periodic monitoring in multiple myeloma management
• Assessing prognosis in lymphoma or chronic lymphocytic leukemia
• When clinician suspects increasing tumour burden or relapse
• To support interpretation of monoclonal gammopathy or plasma cell disorders
• When evaluating contribution of renal function to clinical picture

• Convenient at-home venous blood collection by certified phlebotomist
• Accredited Dubai lab processing with timely result delivery
• Useful marker for monitoring treatment response and disease trends
• Supports oncologist decision-making and prognosis assessments
• Results reported with lab-specific reference intervals for clarity

• At-home venous blood draw by an approved phlebotomist
• No fasting usually required unless otherwise instructed
• Inform the collector of known kidney disease, recent infections, or current medications
• Provide valid Emirates ID and physician prescription if required for lab processing